Jeff Yass’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Jeff Yass's CGEM Position: Q3 2026 in Review
Jeff Yass increased its Cullinan Therapeutics (CGEM) stake by 173% in Q3 2026, buying an estimated $867K and bringing the position to 71,351 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #7708.
Jeff Yass first reported a position in CGEM in Q4 2021 and has held it in 18 quarters since. 182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Jeff Yass held 71,351 shares of Cullinan Therapeutics worth $1.1M as of Q3 2026.
- Jeff Yass bought 45,261 Cullinan Therapeutics shares in Q3 2026, an estimated $867K.
- Cullinan Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7708 holding.
- Jeff Yass first reported a position in Cullinan Therapeutics in Q4 2021 and has held it in 18 quarters since.
- 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.